Breaking News

Rentschler Appoints CBO

March 7, 2013

Ternes brings 25 years of experience

Frank Ternes has been appointed chief business officer, responsible for leading the planning, development and execution of all business development, sales, marketing and project management activities at Rentschler Biotechnologie.
 
Mr. Ternes has more than 25 years of experience from operations and technology positions at Boehringer Ingelheim, where he last served as senior vice president of Biopharmaceutical Contract Manufacturing.
 
"Mr. Ternes is an excellent addition to Rentschler's management board," says Dr. Nikolaus F. Rentschler, chief executive officer and owner of Rentschler. "With his broad experience in the contract manufacturing business, he has a keen understanding of technology, a strong customer focus, and a proven track record for achieving success.”
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks